KnowTheStock
Log inCreate free account

Johnson & Johnson

JNJ
S&P 500Dow 30Pharmaceutical Preparation Manufacturing · NEW YORK STOCK EXCHANGE INC.
$254.66last close · market cap 621.40 Billion
Compare with…
55.4SCORE / 100
Our verdictHOLDModerate Growth and ImprovingQtr Ending 2026-06-28 · trend positive

Why Hold

Income statement and cash flow are strong; balance sheet is weak.

Next earnings: 2026-10-13, EPS Forecast: $2.53

What is strong
  • Net Margin is 21.48%
  • Total Debt to Total Assets Ratio is 0.24
  • Cash from Operations Growth is 19.89%
  • Capital Expenditure is Low
  • Net Increase in Cash is Positive
What to watch
  • Revenue Growth is 8.06%
  • Operating Income Growth is 10.25%
  • Net Income Growth is -7.17%
  • Earnings Per Share (EPS) Growth is -7.59%
  • Current Asset to Current Liability Ratio is 1.09
  • Debt Ratio is 0.58
  • Current Debt to Net Income Ratio is 2.11

What changed

Score by quarter

Upgraded from Sell to Hold in the Mar 2026 quarter: 52.6 → 52.4 (-0.2). This quarter: +3.1.

405060Oct 2022Jun 2026

What the score is made of

Income statement64.5 +0.4
Balance sheet30.6 +0.1
Cash flow69.7 +17.9

Change vs previous quarter.

Key numbers · latest quarter

Revenue (TTM)97.93 Billion8.06 % growth
EPS8.64-7.59 % growth
Profit margin21.48 %Profit per $1 of sales
P-E ratio—Not available
Market cap621.40 BillionShares × price
Debt-equity ratio0.58Leverage
Dividend5.24Per share, annual
Next earnings2026-10-13EPS forecast $2.53
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.

About Johnson & Johnson

Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods.

CEO
Alex Gorsky
Employees
152,700
Sector
Manufacturing
Exchange
NEW YORK STOCK EXCHANGE INC.
jnj.com

Similar stocks

Loading…